Advestra advised Salt, a Swiss telecommunications provider, on its high yield bond offering of CHF 100 million senior secured notes due 2028. The notes were issued by Matterhorn Telecom and guaranteed by Matterhorn Telecom Holding as well as Salt Mobile and were priced at 100% of their aggregate principal amount and the coupon will be 5.25% per annum. The notes are expected to […]
NewGAMe has announced the launch of its partial cash tender offer for up to 28,000,000 shares of SIX-listed GAM Holding. The company is part of the investor group comprised of NewGAMe and Bruellan, that controls approximately 9.6%
Under the legal guidance of Swiss law firm, Niederer Kraft Frey (NKF), Zhejiang Huayou Cobalt Co., a global enterprise in the new energy lithium-ion battery material industry, has successfully completed its offering of global depositary
Disruptive Capital Acquisition Company Limited, a SPAC listed on the Euronext Amsterdam Exchange, has transformed into Global InterConnection Group, following its merger with Global InterConnection Group. The transaction, valued at over CHF 200 million, establishes
Santhera Pharmaceuticals Holding has completed a 10:1 reverse split of its shares, which had been approved by the shareholders on June 27, 2023, with the listing and first day of trading of the post-split shares on the SIX
Homburger has provided legal counsel to Santhera Pharmaceuticals Holding (SIX: SANN “Santhera”) on its completion of a 10:1 reverse split of its shares. The reverse split, which was approved by shareholders on June 27, 2023, resulted in the
Schellenberg Wittmer has advised BNP Paribas Suisse in the placement of CHF 410 million dual tranche senior fixed rate notes issued by EnBW International Finance. BNP Paribas Suisse acted as Swiss paying agent and, together with
Evolva Holding announced that it had entered into a new agreement with Nice & Green (N&G) to replace an existing an equity-linked debt instrument issued by Evolva consisting of convertible notes issued in
Alt. Inv. PCC Limited has established an issuance program for structured products – in particular, tracker certificates, actively-managed certificates (AMCs) and credit-linked notes (CLN) – pursuant to the Financial Services Act (FinSA). The prospectus was prepared under
Santhera Pharmaceuticals Holding has announced the grant of an exclusive North America license for the commercialization of vamorolone to Catalyst Pharmaceuticals for a total consideration of up to USD 231 million
